Oppenheimer Upgrades Intuitive Surgical to Outperform, Announces $500 Price Target

Benzinga Newsdesk www.benzinga.com Positive 90.9%

Neg 0% Neu 0% Pos 90.9%

Oppenheimer analyst Suraj Kalia upgrades Intuitive Surgical (NASDAQ:ISRG) from Perform to Outperform and announces $500 price target.